치자 추출물 및 치자로부터 분리된 신규 화합물 및 그 용도
    21.
    发明公开
    치자 추출물 및 치자로부터 분리된 신규 화합물 및 그 용도 失效
    园艺纤维提取物具有免费的放射活性活性和抗病毒活性,其分离的化合物及其用途

    公开(公告)号:KR1020040105183A

    公开(公告)日:2004-12-14

    申请号:KR1020030036482

    申请日:2003-06-05

    Abstract: PURPOSE: Provided are the Gardeniae fructus extract having free radical scavenging activity and antiviral activity, novel compounds isolated therefrom and the use thereof for prevention and treatment of viral diseases, such as AIDS. CONSTITUTION: The Gardeniae fructus extract is obtained by extracting Gardeniae fructus with water or organic solvents. It contains as an active ingredent, methyl-0-caffeoyl-4-0-sinapolylquinate, methyl 3,5-0-dicarffeoyl-4-0-(3-hydroxy-3-methyl)glutaroylquinate, ethyl 5-0-caffeoyl-4-0-sinapoylquinate, methyl -0-caffeoyl--0-sinapoylquinate, ethyl 3-0-caffeoyl-5-0-sinapoylquinate, 3,5-0-dicaffeoylquinic acid, and 4,5-0-dicaffeoylquinic acid.

    Abstract translation: 目的:提供具有自由基清除活性和抗病毒活性的栀子提取物,从其中分离的新化合物及其用于预防和治疗病毒性疾病如AIDS的用途。 构成:栀子提取物通过用水或有机溶剂萃取栀子获得。 它含有作为活性成分的甲基O-咖啡酰基-4-0-辛酰基喹喔啉,3,5-0-二甲酰基-4-0-(3-羟基-3-甲基)戊酰基喹啉甲基,5-0-咖啡酰基 - 4-0-辛酰基喹喔啉,O-咖啡酰基-O-辛酰基喹喔啉,3-0-咖啡酰基-5-0-辛酰基喹喔啉,3,5-0-二苯甲酰奎宁酸,和4,5-0-二茄酸奎宁酸。

    Τ-형 칼슘 채널에 활성을 지닌 신규 1,4-다이아제판 피라졸 화합물
    26.
    发明公开
    Τ-형 칼슘 채널에 활성을 지닌 신규 1,4-다이아제판 피라졸 화합물 有权
    作为T型钙通道拮抗剂的1,4-二氮杂双环衍生物

    公开(公告)号:KR1020120097288A

    公开(公告)日:2012-09-03

    申请号:KR1020110016788

    申请日:2011-02-24

    Abstract: PURPOSE: A pharmaceutical composition containing 1,4-diazepane pyrazole compound and a pharmaceutically acceptable salt thereof is provided to be used as an agent for preventing or treating brain diseases, heart diseases, cancer, epilepsy, and pain. CONSTITUTION: A 1,4-diazepane pyrazole compound is denoted by chemical formula 1. A pharmaceutical composition for preventing and treating brain diseases such as epilepsy, depression, Parkinson's diseases, dementia, sleep disorders, or heart diseases such as hypertension, cardiac arrhythmia, or myocardial infarction, or pain contains the compound of chemical formula 1 as an active ingredient. A method for preparing the compound of chemical formula 1 comprises a step of reacting pyrazolemethyl amine of chemical formula 2 with chloroacetyl chloride.

    Abstract translation: 目的:提供含有1,4-二氮杂环庚烷吡唑化合物及其药学上可接受的盐的药物组合物,用作预防或治疗脑疾病,心脏病,癌症,癫痫和疼痛的药剂。 构成:1,4-二氮杂环庚烷吡唑化合物由化学式1表示。用于预防和治疗脑疾病如癫痫,抑郁症,帕金森病,痴呆,睡眠障碍或心脏病如高血压,心律失常, 或心肌梗塞,或疼痛含有化学式1的化合物作为活性成分。 制备化学式1的化合物的方法包括使化学式2的吡唑甲胺与氯乙酰氯反应的步骤。

    T-형 칼슘 채널에 활성을 지닌 피라조일 피페리딘 화합물
    27.
    发明公开
    T-형 칼슘 채널에 활성을 지닌 피라조일 피페리딘 화합물 有权
    吡唑啉酮化合物作为T型钙通道拮抗剂

    公开(公告)号:KR1020120097287A

    公开(公告)日:2012-09-03

    申请号:KR1020110016787

    申请日:2011-02-24

    Abstract: PURPOSE: A pharmaceutical composition containing pyrazoyl piperidine compounds and pharmaceutically acceptable salt thereof is provided to prevent or treat brain diseases, heard diseases, cancer, and pain. CONSTITUTION: A pyrazoyl piperidine compound is denoted by chemical formula 1. A pharmaceutical composition for treating cerebral diseases, cardiac diseases, cancer, or pain contains the compound of chemical formula 1 as an active ingredient. A method for preparing the compound comprises: a step of reacting piperidine acetate of chemical formula 2 and pyrazole methyl amine of chemical formula 3 of a step of reacting piperidine compound of chemical formula 4 with an aldehyde compound of chemical formula 5 by reduction-amination. [Reference numerals] (AA) Reductive amination

    Abstract translation: 目的:提供含有吡唑基哌啶化合物及其药学上可接受的盐的药物组合物,以预防或治疗脑疾病,听到疾病,癌症和疼痛。 构成:化学式1表示吡唑基哌啶化合物。用于治疗脑疾病,心脏病,癌症或疼痛的药物组合物含有化学式1的化合物作为活性成分。 制备该化合物的方法包括:使化学式2的哌啶乙酸酯与化学式3的吡唑甲胺与化学式4的哌啶化合物与化学式5的醛化合物的还原胺化反应的步骤。 (参考号)(AA)还原胺化

    2-피롤리돈기를 포함하는 옥사졸리디논 유도체 또는 이의 약학적으로 허용 가능한 염 및 이들의 제조방법
    29.
    发明公开
    2-피롤리돈기를 포함하는 옥사졸리디논 유도체 또는 이의 약학적으로 허용 가능한 염 및 이들의 제조방법 有权
    含有2-吡咯烷酮基或其药学上可接受的盐的氧杂环丁酮衍生物及其制备方法

    公开(公告)号:KR1020120056078A

    公开(公告)日:2012-06-01

    申请号:KR1020100117602

    申请日:2010-11-24

    CPC classification number: Y02A50/473 Y02A50/481

    Abstract: PURPOSE: An antibacterial composition containing novel oxazolidinone derivative is provided to ensure antibacterial activity against gram positive bacteria. CONSTITUTION: A novel oxazolidinone derivative with antibacterial activity is denoted by chemical formula 1. A method for preparing the compound of chemical formula 1 or the salt thereof comprises: a step of reacting an amine group of a compound of chemical formula 2 with a compound of chemical formula 3 or 4; and a step of substituting a hydroxyl group of an oxazolidinone derivative or a pharmaceutically acceptable salt thereof with a halogen group or methoxy group. An antibacterial composition contains the oxazolidinone derivative of chemical formula 1 or a salt thereof as an active ingredient.

    Abstract translation: 目的:提供含有新恶唑烷酮衍生物的抗菌组合物,以确保对革兰氏阳性菌的抗菌活性。 构成:具有抗菌活性的新型恶唑烷酮衍生物由化学式1表示。化学式1化合物或其盐的制备方法包括:使化学式2的化合物的胺基与 化学式3或4; 以及将恶唑烷酮衍生物或其药学上可接受的盐的羟基与卤素基或甲氧基取代的步骤。 抗菌组合物含有化学式1的恶唑烷酮衍生物或其盐作为活性成分。

    1,6-이치환-3-아미노-4,5,6,7-테트라하이드로-1H-피라졸로[3,4-c]피리딘-7-온 화합물 및 이 화합물의 제조방법
    30.
    发明公开
    1,6-이치환-3-아미노-4,5,6,7-테트라하이드로-1H-피라졸로[3,4-c]피리딘-7-온 화합물 및 이 화합물의 제조방법 有权
    新的1,6-二异丙基氨基-4,5,6,7-四氢-1H-吡唑并[3,4-C]吡啶-7-酮化合物及其制备方法

    公开(公告)号:KR1020110139988A

    公开(公告)日:2011-12-30

    申请号:KR1020100060138

    申请日:2010-06-24

    CPC classification number: C07D471/04

    Abstract: PURPOSE: A novel 1,6-disubstituted-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-7-one is provided to suppress cancer cells. CONSTITUTION: A 1,6-disubstituted-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-7-one compound is denoted by chemical formula 1. A pharmaceutical composition for anticancer contains the compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. A method for preparing the compound of chemical formula 1 comprises a step of alkylating 3-amino compounds of chemical formula 2 with haloalkylcarbonyl piperazine of chemical formula 3 by alkylating.

    Abstract translation: 目的:提供新颖的1,6-二取代-4,5,6,7-四氢-1H-吡唑并[3,4-c]吡啶-7-酮以抑制癌细胞。 构成:1,6-二取代-4,5,6,7-四氢-1H-吡唑并[3,4-c]吡啶-7-酮化合物由化学式1表示。用于抗癌的药物组合物含有化合物 的化学式1或其药学上可接受的盐作为活性成分。 制备化学式1的化合物的方法包括通过烷基化将化学式2的3-氨基化合物与化学式3的卤代烷基羰基哌嗪烷基化的步骤。

Patent Agency Ranking